Literature DB >> 23101605

Advances in the management of Dupuytren disease: collagenase.

Vincent R Hentz1, Andrew J Watt, Shaunak S Desai, Catherine Curtin.   

Abstract

Dupuytren disease (DD) is a benign, generally painless connective tissue disorder affecting the palmar fascia that leads to progressive hand contractures. Mediated by myofibroblasts, the disease most commonly begins as a nodule in the palm or finger, and can progress where pathologic cords form leading to progressive flexion deformity of the involved fingers. The palmar skin overlying the cords may become excessively calloused and contracted and involved joints may develop periarticular fibrosis. Although there is no cure, the sequellae of this affliction can be corrected. This article focuses on the role of collagen in DD and the development of a collagen-specific enzymatic treatment for DD contractures. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23101605     DOI: 10.1016/j.hcl.2012.08.003

Source DB:  PubMed          Journal:  Hand Clin        ISSN: 0749-0712            Impact factor:   1.907


  3 in total

1.  SNPs previously associated with Dupuytren's disease replicated in a North American cohort.

Authors:  Eric R Anderson; Zhan Ye; Michael D Caldwell; James K Burmester
Journal:  Clin Med Res       Date:  2014-02-26

2.  Proposal for Treatment of Severe Dupuytren Disease in 2 Steps: Progressive Distraction With External Fixator and Collagenase - A Preliminary Case Series.

Authors:  Massimo Corain; Filippo Zanotti; Roberta Sartore; Paolo Pozza
Journal:  Hand (N Y)       Date:  2019-02-22

3.  Percutaneous Needle Fasciotomy versus Collagenase Injection for Dupuytren's Contracture: A Systematic Review of Comparative Studies.

Authors:  Takashi Hirase; Rishi Suresh; Michael O Cotton; Alex Han; Matthew B Burn; Joshua D Harris; Shari R Liberman
Journal:  J Hand Microsurg       Date:  2020-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.